1 Department of Physiology and Biophysics, Hotchkiss Brain Institute, University of Calgary, Health Sciences Centre, Faculty of Medicine, Calgary, Alberta, T2N 4N1, Canada
2 Biochemistry and Molecular Biology, Hotchkiss Brain Institute, University of Calgary, Health Sciences Centre, Faculty of Medicine, Calgary, Alberta, T2N 4N1, Canada
3 Cell Biology and Anatomy, Hotchkiss Brain Institute, University of Calgary, Health Sciences Centre, Faculty of Medicine, Calgary, Alberta, T2N 4N1, Canada
* Author for correspondence (e-mail: jcoorsse{at}ucalgary.ca)
Accepted 26 July 2005
![]() |
Summary |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Key words: Sterol, Negative curvature, Vitamin E, Secretory vesicles, Exocytosis, Polyene antibiotics
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Cholesterol is a major component of native biological membranes. In both model and native membranes cholesterol associates to form discrete, functional microdomains (rafts) that serve as sites for specific protein-lipid interactions (Lucero and Robbins, 2004). Several proteins implicated in the exocytotic process have been shown to associate with cholesterol-rich microdomains (Lang et al., 2001
): these domains have been suggested to be the sites of membrane fusion, although a more recent study suggests them to be negative regulators of the exocytotic process (Salaun et al., 2005
), consistent with other membrane components functioning downstream in the actual triggered membrane fusion event (Coorssen et al., 1998
; Peters and Mayer, 1998
; Peters et al., 1999
; Peters et al., 2001
; Coorssen et al., 2003
). This is at least potentially consistent with either the protein pore or proximity models for fusion. Additionally, cholesterol also serves as a source of negative curvature within the bilayer membrane (Coorssen and Rand, 1990
; Chen and Rand, 1997
) that can lower energy barriers to promote the formation of lipidic fusion intermediates, or support the formation and expansion of proteinaceous pores.
Here we selectively describe a role for lipidic membrane components, specifically cholesterol, in the process of triggered fusion using well-established, stage-specific preparations of cortical vesicles (CVs) isolated from sea urchin eggs. Cortex preparations, consisting of primed, release ready CVs fully docked to the plasma membrane (PM), undergo rapid exocytotic fusion in response to an increase in [Ca2+]free (Vacquier, 1975; Baker and Whitaker, 1978
; Vogel et al., 1991
; Shafi et al., 1994
; Vogel et al., 1996
; Tahara et al., 1998
; Coorssen et al., 1998
; Zimmerberg et al., 2000
; Blank et al., 2001
; Coorssen et al., 2003
). As this fully docked state can restrict access to critical components at the fusion site (Coorssen et al., 1998
; Whalley et al., 2004
) and as the PM can often act as a sink for reagents, experiments were also carried out using the established homotypic CV-CV fusion system (Vogel et al., 1991
; Coorssen et al., 1998
; Szule et al., 2003
). Homotypic fusion has been documented at the cortex and proceeds rapidly through the same molecular mechanism as CV-PM fusion (Chandler, 1984
; Coorssen et al., 1998
; Zimmerberg et al., 2000
; Coorssen et al., 2003
). Cholesterol was removed from membranes using methyl-ß-cyclodextrin (mßcd), an agent known to alter membrane cholesterol levels through direct binding of cholesterol into a hydrophobic pocket (Kilsdonk et al., 1995
; Christian et al., 1997
). Delivery of cholesterol to depleted membranes was accomplished using cholesterol-loaded mßcd, saturated cholesterol solutions (Alivisatos et al., 1977
), and cholesterol-loaded 2-hydroxypropyl-ß-cyclodextrin (hpßcd), a related cyclodextrin with a relatively lower affinity for membrane cholesterol. Studies were also carried out with polyene antibiotics, a class of molecules known to bind and effectively sequester sterols in the membrane (Weissmann and Sessa, 1967
; Norman et al., 1972a
; Norman et al., 1972b
; Patterson et al., 1979
). Cholesterol oxidase was used to metabolically `remove' cholesterol from the membranes and effectively disrupt functional microdomains (Xu and London, 2000
; Samsonov et al., 2001
) The results of these experiments support the role of cholesterol as a pre-fusion organizer (Lang et al., 2001
; Salaun et al., 2005
), but also indicate that cholesterol functions more directly in the native molecular mechanism of bilayer merger.
![]() |
Materials and Methods |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Preparations and fusion assays
Cortical vesicles were isolated from purple sea urchins (Strongylocentrotus purpuratus, Westwind, BC, Canada) as previously described (Coorssen et al., 1998). Animals were stored on site at
7°C. All experiments were carried out in baseline intracellular medium (BIM, 210 mM potassium glutamate, 500 mM glycine, 10 mM NaCl, 10 mM Pipes, 50 µM CaCl2, 1 mM MgCl2, 1 mM EGTA pH 6.7) (Coorssen et al., 2002
) supplemented with 2.5 mM ATP and protease inhibitors, unless otherwise stated. Standard end-point and kinetic fusion assays were carried out as previously described (Coorssen et al., 1998
; Coorssen et al., 2003
; Szule et al., 2003
), with some modifications. CV-PM preparation (cell surface complexes, CSCs) endpoint and kinetic fusion assays were carried out on free-floating CSCs, with suspensions maintained by gentle shaking steps. During kinetic measurements CSCs were kept suspended by 2 second shaking steps (Wallac Victor II microplate reader) between the measurement of each well. Each condition was tested in sets of four replicates per experiment, and each experiment was repeated as indicated (n); data are reported as mean ± s.e.m. Final free Ca2+ concentrations ([Ca2+]free) were measured with a Ca2+ sensitive electrode (World Precision Instruments, Sarasota, FL) for each condition in every experiment, as previously described (Coorssen et al., 1998
; Coorssen et al., 2003
). Ca2+ activity curves were fit using the sigmoidal cumulative log-normal model (Blank et al., 1998
); control conditions were fit with a two-parameter model (by definition reaching 100% fusion), whereas experimental conditions were fit with a 3-parameter model (TableCurve 2D) to determine the upper plateau extent, Ca2+ sensitivity and sigmoidal-slope parameters of fusion. In the kinetic assays, a rapid phase of fusion was apparent during the period of Ca2+ injection (450 mseconds) corresponding to a rate of CV fusion reported here as the initial fusion rate (% fusion/second). Lysis was confirmed by light microscopy, and measured as a change in optical density after incubation with mßcd. Two-sample, two-tailed t-tests were used to determine differences (P<0.05) of fusion parameters between the experimental conditions and parallel, internal controls.
CSC and CV treatments
Saturated cholesterol was prepared as previously described (Alivisatos et al., 1977). Polyene antibiotics were delivered from dimethylsulphoxide (DMSO) stock solutions to a final concentration of <1% DMSO, while
-tocopherol (
-toc) and dioleoylphosphatidylethanolamine (DOPE) were delivered using hexadecane to a final solvent concentration of 0.05%; parallel solvent controls were carried out in every experiment but never significantly affected fusion. Stock solutions of mßcd, hpßcd,
cd, and ßcd were prepared by dissolving in BIM working buffer and added to CV suspensions at the indicated concentrations. Mßcd- and hpßcd-cholesterol were prepared as previously described (Racchi et al., 1997
; Sheets et al., 1999
; Hao et al., 2002
); briefly, cholesterol dissolved in chloroform:methanol (2:1 v/v) was dried under a stream of nitrogen and trace solvent was removed under vacuum for 2 hours. An appropriate volume of 100 mM mßcd or hpßcd was added to the dried film at a standardized molar ratio (
8:1 for mßcd:cholesterol and 10:1 for hpßcd:cholesterol) and vortexed to suspend the film. Suspensions were bath sonicated for 20 minutes, then incubated overnight at 37°C with shaking (250 rpm). Finally, suspensions were cooled to room temperature and filtered through 0.2 µm filters (Fisher Scientific, Hampton, NH) to clarify solutions. CSC and CV suspensions (OD 1.00±0.05) were treated with mßcd for 30 minutes (25°C), followed by centrifugation to isolate the preparations. Resulting supernatant samples were cleared of all membrane fragments by ultra-centrifugation (100,000 g for 3 hours), and stored at 80°C until analyzed. Isolated CSCs and CVs were then suspended in BIM (OD 0.39±0.02); an aliquot was used for fusion assays, and the remainder stored at 80°C prior to lipid analysis. Cholesterol oxidase treatments were carried out at 30°C in BIM, pH 7.0, for 30 minutes. For treatments with reversible inhibitors (filipin, ampB, PIM, and LPC) CVs were either treated at an optical density of 1.00±0.05 and then diluted after incubations (for filipin, ampB and PIM) or treated at a final dilution of 0.40±0.02 (for LPC). Fusion assays were then carried out immediately. In all cases fusion assay results were normalized against those of controls handled in parallel.
Molecular analyses
Quantification of cholesterol in CV membrane fractions after mßcd treatments was carried out using the Amplex Red Cholesterol Assay kit (Molecular Probes, Eugene, OR) according to the manufacturer's instructions.
CV membrane lipids were extracted according to Bligh and Dyer (Blich and Dyer, 1959) with some modifications. Lipids were extracted by the sequential addition of methanol, and then chloroform, to an intermediate ratio of 0.8:2:1 (H2O:CH3OH:CHCl3, v/v/v) and subsequently brought to a final ratio of 1.8:2:2 through sequential addition of aqueous solution (1 M NaCl, 0.1 M HCl in water) and CHCl3. The resulting organic phase was recovered, dried under vacuum and stored under nitrogen at 30°C. Dried lipid films were resuspended in CHCl3:CH3OH (2:1 v/v) for high performance thin layer chromatography (HPTLC) analysis. HPTLC was carried out according to Weerheim et al. (Weerheim et al., 2002) with modifications. Extracted lipids dissolved in CHCl3:CH3OH were loaded onto silica gel 60 HPTLC plates (CAMAG Linomat IV; Wilmington, NC) pre-washed with CH3OH:ethyl acetate (6:4) and activated at 110°C for 30 minutes. Using the automated, sequential separation steps enabled by the CAMAG AMD 2 multi-development unit, lipids were resolved to 50 mm using CHCl3:ethyl acetate:acetone:isopropanol:ethanol:methanol:water:acetic acid (30:6:6:6:16:28:6:2, v/v), then to 78 mm with dichloromethane:ethyl acetate: acetone (80:16:4, v/v/v), and finally to 90 mm with hexane: ethyl acetate in three steps (85:15, 92:8, and 100:0 v/v, sequentially). Separated lipids were visualized with Nile Red (Fowler et al., 1987
) and imaged (Ex 540 nm/Em 620 nm) with the PROXPRESS multi-wavelength fluorescent imager (Perkin Elmer, Boston, MA). For phospholipid quantification on HPTLC plates, the integrated Nile Red fluorescent signal for each species of interest was compared to a parallel dilution series of standard phospholipids. Extraction efficiency was estimated by collecting and lyophilizing the aqueous phase remaining after lipid extraction, and analyzing these lipid samples in parallel with the organic phase. We observed consistent recovery of 90±7% for total phospholipid by this method (n=4). Two-sample, two-tailed t-tests were used to determine differences (P<0.05).
![]() |
Results |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
|
|
Direct effects of cholesterol depletion on vesicle fusion
Well established homotypic CV-CV fusion assays yield characteristic sigmoidal Ca2+ activity curves (Vogel et al., 1991; Vogel et al., 1996
; Coorssen et al., 1998
; Blank et al., 1998
; Szule et al., 2003
) with an EC50 of 36.1±7.0 µM [Ca2+]free following an hour or more incubation in vitro (Fig. 3A, black circles; n=4); these are translationally invariant to the CV-PM curves shown in Fig. 1A (Vogel et al., 1996
; Coorssen et al., 1998
; Blank et al., 1998
; Coorssen et al., 2003
). The initial rate of fusion was 57.8±4.4%/second (n=3) in response to 71±21 µM [Ca2+]free. Treating isolated, free-floating CVs with increasing concentrations of mßcd prior to fusion assays resulted in a progressive, dose-dependent rightward shift in Ca2+ sensitivity (to 240±4 µM [Ca2+]free) and a parallel loss in the extent of fusion (Fig. 3A, orange squares). Kinetics of fusion were also inhibited in a dose-dependent manner (Fig. 3B); the initial rate of fusion decreased to 4.6±1.9%/second (n=3) following treatment with 4 mM mßcd. Inhibition of CV-CV fusion was more sensitive to mßcd than was CSC fusion, probably due to higher mßcd concentrations relative to CV resulting from the absence of PM cholesterol. Lysis of isolated CVs was also more sensitive to mßcd concentration, however, at lower concentrations (
2 mM), lysis did not exceed 10% (Fig. 2C). It was also noted that the time course of inhibition by mßcd, which was maximal within
30 minutes, was independent of lysis, which generally occurred within 1 minute (data not shown). The dose-dependent inhibition of the extent of fusion was mathematically correlated to the number of intact, active fusion sites (<n>) per vesicle as previously described (Vogel et al., 1996
; Coorssen et al., 1998
; Blank et al., 1998
) and extrapolated to estimate the number of fusion machines per native vesicle (<n>Max; Fig. 4 open symbols). The resulting estimates, <n>Max=6.5±2.7 (n=4) for CSCs, and <n>Max=5.7±1.2 (n=5) for CVs, are consistent with previously reported values (Coorssen et al., 1998
; Coorssen et al., 2003
).
|
|
The ATP dependence of mßcd inhibition was examined by excluding ATP from buffers both during treatment and during the fusion assay. As previously established, the Ca2+-triggered fusion steps occur independently of ATP (Vacquier, 1975; Baker and Whitaker, 1978
; Vogel et al., 1991
; Coorssen et al., 1998
; Zimmerberg et al., 2000
), and there was also no effect of ATP on the inhibitory activity of mßcd (data not shown). Furthermore, the inhibition by mßcd was not reversed by simply removing mßcd from the buffers. Washing CVs (up to four wash steps) following mßcd treatment had no effect on the extent of inhibition, and there was no residual mßcd detected by HPTLC (data not shown). Thus, the inhibition of the extent of fusion, together with marked declines in Ca2+ sensitivity and the rate of fusion, were related to the proportion of cholesterol removed from the CV membranes (Fig. 3C) rather than to an effect of residual mßcd bound to the membrane.
HPTLC analyses revealed that the mßcd treatments only removed limited amounts of other lipidic components from CV membranes relative to cholesterol (Fig. 5D). The specificity of the observed relationship between removal of cholesterol and inhibition of fusion was confirmed by using other cyclodextrins that are less selective for cholesterol (Kilsdonk et al., 1995). The
- and ß-cyclodextrins (
cd and ßcd) as well as hpßcd had no significant effect on the extent, Ca2+ sensitivity or kinetics of triggered fusion at comparable doses to mßcd (Fig. 5A,B); however, at higher doses (5 mM), ßcd had a slight (but not statistically significant) inhibitory effect on Ca2+ sensitivity (Fig. 5A, yellow diamonds), while
cd had inhibitory effects on fusion kinetics (Fig. 5E, green triangles). In response to 87±3 µM [Ca2+]free, the initial rate of fusion decreased from 60.4±1.2%/second to 27.1±1.2%/second following treatment with 5 mM ßcd (n=2). Very high (
20 mM) doses of hpßcd also inhibited the Ca2+ sensitivity, but not the extent of fusion (Fig. 5B, purple inverted triangles). Relative to the effects of an identical dose of mßcd (2 mM), there was no substantial removal of CV membrane cholesterol by any of these other cyclodextrins (Fig. 5C,D), although at higher doses each of the cyclodextrins tested removed significant amounts of cholesterol (P<0.001, Fig. 5C). Thus, overall, the dose-dependent effects of mßcd treatments on triggered fusion (as well as those of the other cyclodextrins at higher doses) correlated directly with the removal of CV cholesterol. If this is indeed a cause-effect relationship, the ability of CVs to fuse should be rescued by the addition of exogenous cholesterol to cholesterol-depleted CVs.
|
|
|
|
Testing for specific roles of cholesterol
In order to further characterize the effects of altering cholesterol levels in the membrane, and to test the hypothesis of two select roles for cholesterol in the fusion pathway, we sought additional methods of altering the effective cholesterol concentration in the membrane. As oxidized cholesterol (the ketone, cholesten-3-one) is known to disrupt rafts (Xu and London, 2000; Samsonov et al., 2001
), we enzymatically manipulated cholesterol levels in the CV membrane using cholesterol oxidase (Fig. 8A). The resulting inhibition of fusion extent was dose dependent, correlating with total cholesterol levels. Only following treatments with very high enzyme concentrations (1 U/ml cholesterol oxidase) that caused a loss of 52.3±0.5% of the total CV cholesterol, was Ca2+ sensitivity also significantly shifted to the right (Fig. 8B, green triangles). Thus, effects on the efficiency of fusion were only seen when cholesterol was depleted to levels comparable to those seen after treatments with mßcd (Fig. 6E, Table 1).
|
|
Cholesterol as a critical negative curvature membrane component
Since cholesterol acts in the membrane as a molecule supporting negative curvature, and also through interactions with membrane proteins and other membrane constituents, we investigated the effects of alternative curvature analogues in cholesterol-depleted membranes. In a direct physical role, cholesterol could act focally at the fusion site to promote/support the formation of highly curved fusion intermediates. If this hypothesis concerning the negative curvature of cholesterol facilitating the native triggered fusion mechanism is correct, then introduction of other negatively curved molecules should rescue the ability to fuse whereas the introduction of positive curvature components would be expected to further inhibit fusion in cholesterol-depleted CV. Lysophosphatidylcholine (LPC) is a native membrane component of high positive curvature that has been previously shown to cause potent, dose-dependent, fully reversible inhibition of Ca2+-triggered membrane fusion (Chernomordik et al., 1993; Vogel et al., 1993
; Gunther-Ausborn et al., 1995
; Chernomordik et al., 1995a
; Chernomordik et al., 1995b
). Addition of a low dose of LPC caused reversible inhibition of the extent of fusion, without significant effect on Ca2+ sensitivity (Fig. 10A, yellow circles); the same dose of LPC added to cholesterol-depleted CV further inhibited the extent of fusion (Fig. 10A, red squares). Inhibition by LPC was fully reversed by adding 1 mM hpßcd (Fig. 10B, purple triangles). Hpßcd was found to act as a molecular sink, apparently binding excess LPC in solution, and thus shifting the intercalation equilibrium of LPC with the membrane. The addition of 1 mM hpßcd to mßcd- and LPC-treated CVs again reversed the inhibition, back to that originally observed following mßcd treatment alone (Fig. 10B, green squares). Addition of exogenous cholesterol to mßcd-treated, LPC-inhibited CVs resulted in the full recovery of both the extent and Ca2+ sensitivity of fusion (Fig. 10B, orange diamonds).
|
Two other membrane components of high intrinsic negative curvature, -tocopherol (
-toc) and dioleoylphosphatidylethanolamine (DOPE) (Rand et al., 1990
; Epand et al., 1996
; Leikin et al., 1996
; Chen and Rand, 1997
; Bradford et al., 2003
), were tested for their ability to substitute for cholesterol in selectively rescuing fusion ability. Incorporation of
-toc or DOPE into cholesterol-depleted CVs produced a selective recovery of fusion extent, without rescuing either Ca2+ sensitivity or kinetics (Fig. 11A,B); the resulting Ca2+ activity curves remained translationally invariant relative to parallel controls. In response to 111±14 µM [Ca2+]free, the initial rate of fusion was 68.1±5.5%/second before treatment and 9.0±2.5%/second after 2 mM mßcd treatment; following recovery with
-toc and DOPE the initial fusion rates were 14.9±2.2%/second and 18.2±1.7%/second, respectively (n=3). Initial fusion rates following delivery of DOPE and
-toc to the CV membrane were not significantly different from that following treatment with 2 mM mßcd. Membrane incorporation of both
-toc and DOPE was verified by HPTLC (data not shown). Since both
-toc and DOPE are native membrane components of high negative curvature, but without the ability to promote the formation of rafts comparable to those containing cholesterol, their selective rescue of the extent of fusion (but not Ca2+ sensitivity or kinetics) is consistent with the idea that negative curvature agents promote or support transient fusion intermediates, whereas the full, physiological Ca2+ sensitivity of fusion involves the interaction of additional factors through cholesterol-rich microdomains.
|
![]() |
Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
CV functional characteristics and membrane composition
CVs are reasonably well characterized, both functionally and physically. Here, we confirm the robust consistency of previously established curve shape parameters and the translational invariance of the classic sigmoidal Ca2+ activity curves for both CV-PM and CV-CV fusion, and the rapid kinetics of fusion (Vogel et al., 1991; Vogel et al., 1996
; Coorssen et al., 1998
; Blank et al., 1998
; Blank et al., 2001
; Coorssen et al., 2003
; Szule et al., 2003
). The slight rightward shift in Ca2+ sensitivity (EC50) reported here, relative to previous work, is the result of the 3-4°C lower holding temperature we now use to better maintain the gravid adult urchins in captivity.
Cholesterol is a major component of the CV membrane (Decker and Kinsey, 1983), and of many other types of secretory vesicles (Table 2). Here we report a cholesterol:phospholipid ratio of 0.602±0.034 for the CVs of S. purpuratus. An earlier study reported a ratio of 1.33±0.12 for Lytechinus variegatus (Decker and Kinsey, 1983
). Such differences are not unexpected between species, particularly considering the different native environments; L. variegatus is found in the warmer waters off the coast of Florida, and S. purpuratus in the cold waters off the coast of British Columbia. It is known that organisms vary the lipid composition of cellular membranes in response to temperature (Jin et al., 1999
; Rilfors and Lindblom, 2002
; Sanina and Kostetsky, 2002
), and as increasing total concentrations of cholesterol tend to increase order and generally decrease the fluidity of bilayer membranes, animals inhabiting warmer waters would be expected to have a higher proportion of membrane cholesterol. The importance of cholesterol in exocytosis is suggested by the substantial difference in cholesterol content between the CVs and plasma membranes. Decker and Kinsey reported CV membrane cholesterol to be fully 2.3-fold higher than that of the plasma membrane (Decker and Kinsey, 1983
). Secretory vesicles from various tissues and across numerous species are likewise enriched in cholesterol (summarized in Table 2). Reported cholesterol:phospholipid ratios vary from 0.34 to 1.04, with most vesicle types being significantly enriched in cholesterol relative to the plasma membrane, as with CVs.
|
Cholesterol depletion correlates with loss of fusion capacity
Inhibition of exocytosis and the depletion of cholesterol from CV-PM preparations are strongly correlated, and independent of indirect effects of mßcd. As we have rigorously characterized the lytic properties of mßcd in our preparations, we can clearly and consistently differentiate between fusion, lysis or undocking. Inhibition of fusion by mßcd does not result from lysis, which occurs on a substantially faster time scale. Furthermore, despite the known microdomain destabilizing effects of mßcd, and the noted dispersal of SNARE proteins (Lang et al., 2001), there was no evidence of CV undocking from the PM (Fig. 2A), consistent with previous findings that inter-membrane SNARE protein interactions do not specifically define the docked state (Coorssen et al., 1998
; Coorssen et al., 2003
). This stably docked state of CVs in mature oocytes perhaps explains why we find no evidence for undocking, in contrast to the observed effects on insulin secretory granules following treatment of intact cells with mßcd (Ohara-Imaizumi et al., 2004
); perhaps these latter vesicles were tethered but not yet fully docked. Disruption of rafts may thus interfere with the docking process but not effectively reverse docking once established. Resolution of this question will require better molecular and physical understanding of the tethered and docked states.
Like CV-PM fusion, CV-CV fusion was also significantly inhibited by mßcd, independent of its earlier lytic effects (Fig. 2C). Since lysis by mßcd is quite rapid (<<1 minute) compared to the slower timecourse for inhibition of the extent, Ca2+ sensitivity and kinetics of fusion (10 minutes) these effects are well separated and thus unlikely to be related. Additionally, inhibition of fusion by removal of cholesterol is not a result of vesicle de-priming. As the CVs are by definition docked, primed and release ready, Ca2+-triggered CV-PM and CV-CV fusion are ATP independent (Vacquier, 1975
; Baker and Whitaker, 1978
; Vogel et al., 1991
; Shafi et al., 1994
; Vogel et al., 1996
; Tahara et al., 1998
; Coorssen et al., 1998
; Zimmerberg et al., 2000
; Blank et al., 2001
; Coorssen et al., 2003
; Whalley et al., 2004
). Likewise, the effects of mßcd were also independent of ATP; exclusion of ATP from buffers both during mßcd treatments and during Ca2+ activity (fusion) assays had no effect on the parameters of triggered fusion, precluding effects such as de-priming and subsequent ATP-dependent re-priming upon supplementation with exogenous cholesterol. Thus, despite a suggested role for cholesterol in priming (Kato and Wickner, 2001
; Fratti et al., 2004
), this stage is clearly not as labile in CVs.
One possible interpretation of the rightward shift in Ca2+ sensitivity following cholesterol depletion is a change in the local [Ca2+]free due to alteration of the local lipid composition at the fusion site. The measurement of local, near-membrane Ca2+ concentrations remains problematic, and as a result, all work in the field is limited to measures of bulk [Ca2+]free. The relationship between bulk and local [Ca2+free]free thus remains an unknown variable, particularly in terms of routine, direct measurements. However, in these experiments, such an alteration in the local [Ca2+]free at fusion sites, resulting from local compositional changes of lipids, appears unlikely. Considering the very rapid transbilayer movement of cholesterol [t1/2 1 second (Leventis and Silvius, 2001
; Steck et al., 2002
)], its removal from the outer leaflet of the CV membrane would be expected to cause a redistribution of lipids from the inner leaflet, resulting in an increased density of charged lipids on the outer monolayer. This would only serve to increase the local [Ca2+]free at membrane interfaces, and potentiate fusion via the inter-bilayer binding of Ca2+ between the anionic lipid headgroups (Feigenson, 1989
; Coorssen and Rand, 1995
). Such potentiation of fusion was never seen.
Since cyclodextrins are generally able to bind numerous hydrophobic or lipophilic molecules, we must ask if we have correctly identified cholesterol as the primary target of mßcd, and thus as the critical membrane component correlating with the observed inhibitory effects. The first indication that inhibitory effects of mßcd correlated with the selective removal of CV cholesterol came from coupled molecular-functional analyses of the effects of related cyclodextrins. At doses comparable to that of mßcd, cd, ßcd and hpßcd neither inhibited fusion, nor affected CV membrane cholesterol concentrations (Fig. 5), but did extract a similar complement of other lipids from the membrane (Fig. 5D). However, at higher doses each cyclodextrin produced some inhibitory effects on fusion parameters, correlating with significant removal of cholesterol from the CV membrane, comparable to that seen with mßcd. Higher doses of
cd had inhibitory effects on fusion kinetics (Fig. 5C) whereas ßcd caused slight inhibitory effects on Ca2+ sensitivity (Fig. 5A). In both cases the extent of inhibition and cholesterol removal was approximately equivalent to that seen following the treatment of CVs with 1 mM mßcd. Thus, mßcd is
5-fold more potent than either
cd or ßcd in removing CV membrane cholesterol. As hpßcd does not have significant inhibitory effects at concentrations of<20 mM, mßcd is
10-fold more potent than this analogue. The somewhat selective effects of the different cyclodextrins,
cd for kinetics and ßcd or hpßcd for Ca2+ sensitivity are most probably explained by somewhat differential targeting of membrane microdomains and/or the selective solubilization of other components within these rafts (Elliott et al., 2003
; Kiely et al., 2003
; Aachmann et al., 2003
; Bacia et al., 2004
).
The dose-dependent inhibition of fusion by mßcd can most simply be described in terms of two parameters the extent and Ca2+ sensitivity of fusion as it is known that the latter is directly related to the kinetics (rate) of fusion via Ca2+ activation of fusion complexes (Blank et al., 2001). The effect of mßcd on membranes is likewise twofold and inter-related, causing the dose-dependent removal of cholesterol from membranes, and the subsequent disruption of cholesterol-rich microdomains, resulting in the dispersal of raft constituents. Here we show, for the first time, that the two fusion parameters are separable, and related to the two molecular effects of mßcd treatment.
Membrane domains and the recovery of fusion efficiency
The addition of exogenous cholesterol to cholesterol-depleted membranes results in a dose-dependent recovery of ability to fuse (e.g. the extent of fusion), but full rescue of the Ca2+-sesitivity and kinetics of fusion only occurs upon recovery of membrane cholesterol to native levels (Fig. 6). The separation of the two inhibited fusion parameters, ability to fuse and efficiency of fusion, allows us to speculate as to the mechanism of inhibition by mßcd. First, mßcd removes cholesterol from membranes in a dose-dependent manner. This is recovered through the addition of exogenous cholesterol to the CVs, but results in a graded recovery of only the extent of fusion (Fig. 6A). Second, mßcd is disruptive to cholesterol-rich microdomains, and causes the dispersal of raft constituents (e.g. proteins and other lipid components). In order to fully recover both the ability of CVs to fuse and the efficiency of fusion, both recovery of native cholesterol levels and reformation of appropriate cholesterol-rich microdomains appear to be necessary. The spontaneous recovery of the Ca2+ sensitivity and kinetics of fusion after full recovery of the native CV membrane cholesterol level is consistent with a critical total cholesterol concentration required to support formation of rafts (Parasassi et al., 1995). Additionally, model membrane studies show that increasing cholesterol concentration in lipid bilayers results in a decreased transition temperature to the liquid ordered phase (Parasassi et al., 1995
; Filippov et al., 2003
). Thus, at a fixed temperature, varying the cholesterol concentration in membranes identifies a critical concentration of cholesterol for the `spontaneous' transition to the liquid ordered phase. Certainly the presence of other specific membrane components will also promote the local formation of domains, as will the rapid rate of transbilayer redistribution (e.g. flip-flop) that is characteristic of cholesterol in biological membranes (Leventis and Silvius, 2001
; Steck et al., 2002
).
Microdomain disruption affects Ca2+ sensitivity of fusion
To further understand the apparent dual effect of mßcd on Ca2+-triggered fusion, in that it inhibits both the extent and the Ca2+ sensitivity of fusion, we carried out treatments having alternate effects on membrane cholesterol. Enzymatic manipulation of CV membrane cholesterol with cholesterol oxidase resulted first in potent inhibition of the extent of fusion, followed by inhibition of the Ca2+ sensitivity only after more aggressive enzyme treatments (Fig. 8), comparable to the effects of mßcd (Fig. 3). The ketone end product of cholesterol oxidation, cholesten-3-one, is known to inhibit domain formation in model membranes (Xu and London, 2000) and to cause dispersal of microdomain constituents (Samsonov et al., 2001
). Thus, cholesterol oxidase functionally removes cholesterol from the membrane by conversion to a dissimilar end product, while it physically eliminates functional microdomains through the disruptive effects of high local cholesten-3-one concentrations.
Contrary to the effects of both mßcd and cholesterol oxidase treatments, it has previously been shown that polyene antibiotics do not effectively disrupt rafts in a manner consistent with the effects of mßcd (Awasthi-Kalia et al., 2001); the mode of action of filipin (Norman et al., 1972a
; Norman et al., 1972b
; Lopes et al., 2004
), the best studied of the polyene antibiotics, suggests a cholesterol clustering action rather than a broadly disruptive action. Likewise, the widespread use of filipin as a fluorescent and ultrastructural probe for membrane sterol clustering also argues against effective or extensive domain disruption (Orci et al., 1981
; Keller and Simons, 1998
; Gagescu et al., 2000
; Grebe et al., 2003
; Fratti et al., 2004
). In this study, we carefully selected concentrations of polyene antibiotics to approximate stoichiometric ratios with total CV cholesterol. The highest dose of filipin (76 µM) corresponds to an approximate 1:2 ratio of filipin to outer leaflet cholesterol (mol/mol); lower doses correspond to 1:4, 1:10 and 1:100 filipin:cholesterol. As estimates of the stoichiometry of cholesterol:filipin binding ratio are approximately 1.5-2:1 (Norman et al., 1972b
), the treatment with 76 µM filipin correlates to approximately 50% total cholesterol binding. Comparable removal of cholesterol from CVs by 4 mM mßcd treatment results in approximately 60% inhibition of fusion extent (Fig. 3A, orange squares), consistent with the inhibition by filipin (Fig. 9A, yellow squares). Since all polyene antibiotics tested dose-dependently affected the extent of fusion, with no significant effects on the Ca2+ sensitivity of fusion, we interpret the latter as indicating that raft constituents are not effectively or generally dispersed (Awasthi-Kalia et al., 2001
). Rather, it would appear that functional aggregates of critical domain components are locally retained, but inhibited. In all other examples (Figs 1, 3, 8), the treatments known to consistently disrupt cholesterol-rich microdomains correlate directly with rightward shifts in the Ca2+ sensitivity of fusion.
Supplementation of native CV membranes with exogenous cholesterol results in a statistically insignificant leftward shift in the Ca2+ sensitivity of fusion, and a likewise insignificant promotion of the kinetics of fusion (Fig. 7), despite an increase in CV cholesterol to 152±9% (n=3). This implies that the lipid components of the CV membrane are carefully `tuned' to a critical cholesterol concentration that supports the formation and maintenance of functional microdomains (Parasassi et al., 1995). The effects of supplementing cholesterol above native densities does not yield more efficient domains that further promote the Ca2+ sensitivity or kinetics of fusion.
Cholesterol contributes negative curvature to the fusion process
As we have identified correlations between changes in the Ca2+ sensitivity of fusion and treatments that disrupt rafts, we also sought to test for correlations between the observed changes in extent of fusion with the second proposed role of cholesterol in the CV membrane. In addition to the organizational role cholesterol plays in the formation and maintenance of microdomains, it also contributes negative curvature stress to lipid bilayers (Coorssen and Rand, 1990; Rand et al., 1990
; Chen and Rand, 1997
). Thus, with its intrinsic negative curvature and high focal density in certain membrane microdomains, this abundant native sterol (and perhaps related molecules) could well serve to reduce local energy constraints and thereby promote the progression of energetically favourable fusion intermediates.
The dose-dependent recovery of the extent of fusion with exogenous cholesterol delivery, without parallel rescue of the Ca2+ sensitivity (Fig. 6A), suggests that the curvature role of cholesterol in the CV membrane is selectively associated with fusion ability. Exogenous cholesterol can also overcome the inhibitory effects associated with the incorporation of LPC (high positive curvature) in the vesicle membrane (Fig. 10A). The fully effective and selective recovery of the fusion ability of CVs (extent of fusion), following incorporation of the native `curvature analogues' -toc and DOPE (Epand et al., 1996
; Bradford et al., 2003
), is also fully consistent this hypothesis (Fig. 11). Since neither
-toc nor DOPE are capable of supporting the formation of functional microdomains comparable to those involving cholesterol, the contribution of
-toc and DOPE to the process of Ca2+-triggered membrane merger is most simply interpreted in terms of a direct physical contribution of local curvature stress, promoting or supporting the formation of highly curved, transient fusion pore intermediates. Additionally, since all recovered fusion curves, including those for each cholesterol delivery method as well as the recoveries with DOPE and
-toc, are translationally invariant to Ca2+ activity curves for untreated control CVs, recovered membrane fusion still proceeds through the same molecular mechanism (Vogel et al., 1996
; Blank et al., 1998
).
Changes in fusion parameters in response to inhibitory reagents has been the subject of elegant mathematical analysis and modelling (Vogel et al., 1996; Tahara et al., 1998
; Blank et al., 1998
; Blank et al., 2001
). Such analyses have been used here to reveal characteristics of the inhibitory effects of mßcd. As the Ca2+ activity curves of both CSCs and CVs treated with various concentrations of mßcd are translationally invariant with respect to untreated controls and each other, it is not that fusion is proceeding via an alternate pathway, but rather that native fusion machines are progressively inactivated as increasing amounts of cholesterol are lost from the membrane. Thus, we can extrapolate back from the progressive decline in the extent of fusion in order to estimate the total number of functional fusion machines (<n>Max) on a native vesicle (Fig. 4) (Vogel et al., 1996
; Blank et al., 1998
). Since these values are both internally consistent, and consistent with previously reported values of <n>Max (Coorssen et al., 1998
; Coorssen et al., 2003
), we conclude that the inhibition of fusion by mßcd is a direct result of a decrease in the number of intact, active fusion machines per vesicle. This implies that cholesterol is itself a component of the fusion machinery, or is at the very least intimately associated with and influencing critical components. Thus, through cholesterol removal and subsequent replacement, we have effectively `switched' fusion machines off and on.
Although perhaps most consistent with the stalk-pore hypothesis of fusion pore formation (Kozlov and Markin, 1983; Chernomordik and Zimmerberg, 1995
; Chernomordik et al., 1995a
; Chernomordik et al., 1995b
; Chanturiya et al., 1997
; Kozlovsky et al., 2002
), alternate local effects of cholesterol including the direct facilitation of protein-based pores can not be excluded. Nonetheless, these studies clearly differentiate the dual role of cholesterol in the process of Ca2+-triggered membrane fusion: as a prefusion organizer contributing to the efficiency of fusion (e.g. Ca2+ sensitivity and kinetics) and as a native membrane component, critical to fast, functional fusion machinery, contributing negative curvature to facilitate the formation and/or expansion of fusion intermediates, thereby supporting the intrinsic ability of vesicles to fuse.
Cholesterol as a component of the fusion machine
The direct role of cholesterol in Ca2+-triggered membrane fusion can be interpreted in two ways. The simplest interpretation is that cholesterol contributes negative curvature to the membrane, promoting the formation of transient lipidic fusion intermediates (Kozlov and Markin, 1983; Chernomordik and Zimmerberg, 1995
; Chernomordik et al., 1995a
; Chernomordik et al., 1995b
; Chanturiya et al., 1997
; Kozlovsky et al., 2002
). Of increasing complexity, in a proteinaceous fusion pore model, cholesterol could contribute to the mixing and coalescence of apposed membranes via expansion of a proteinaceous fusion pore (Lindau and Almers, 1995
; Peters and Mayer, 1998
; Bayer et al., 2003
). In this model, lipids with negative curvature could be seen as essential to pore invasion, expansion and subsequent mixing of two bilayers following the initial opening of a protein pore. The well characterized disruption of rafts by mßcd, in many different biological membranes, also results in the irreversible destabilisation of protein interactions and the dispersal of protein components. In secretory cells, such microdomains are critical to a range of pre-fusion states, and domain disruption has been shown to result in the dispersal of proteins that function in the exocytotic pathway (Lang et al., 2001
; Chamberlain et al., 2001
; Kato and Wickner, 2001
; Ohara-Imaizumi et al., 2004
). This generalised deterioration of regulatory interactions and the resulting dispersal of proteinaceous components seems more difficult to reconcile with a channel-like pore model of fusion. It is unclear how protein subunits would effectively oligomerize within a single bilayer following extensive domain disruption, or how such hypothetical semi-pores would then identify and link with their counterparts in an apposed bilayer (also having disrupted domains), to form a complete fusion pore. Alternatively, if the existing pores do not disperse upon treatment with mßcd, but are locally retained, intact, but in an inactive state, only an increase in the effective local cholesterol concentrations might be required to support their functional state. Such pre-formed, activation-ready fusion pores might explain the recovery of the ability to fuse with cholesterol supplementation, but not the depressed kinetics or Ca2+ sensitivity, that are only recovered at full native levels of CV cholesterol (Fig. 6A). Thus, although cholesterol add-back might result in the specific recruitment of protein subunits to form a pore in the plane of a membrane, considering the protein subunits of known channels this will require substantial further investigation particularly in light of, (i) the characteristic dispersal of integral membrane proteins following mßcd treatment (Lang et al., 2001
); (ii) the direct, dose-dependent recovery of native fusion by cholesterol itself (Fig. 6); (iii) the ability of curvature analogues (
-toc and DOPE) to fully support the ability of cholesterol-depleted membranes to fuse (Fig. 11).
The observed effects on the Ca2+ sensitivity of fusion also raise interesting questions. In particular, the selective recovery effects of cholesterol and other curvature analogues raises the issue of why Ca2+ sensitivity remains fixed while extent of fusion is fully recovered (as with DOPE and -toc). One interpretation is that the conventional model of a fusion machine as a single defined complex of protein and lipid components is an oversimplification. Here we confirm that vesicles contain a distribution of fusion machines with varied sensitivity to Ca2+ (Blank et al., 1998
), but show also that fusion sites are able to recover with alternate lipidic components, resulting in functional fusion sites with Ca2+ sensitivities that are right-shifted relative to the native sites. Effectively, fusion machines are re-activated but Ca2+ sensitivities remain low. Clearly the recovered fusion sites are equally potent in terms of the ability to effect fusion in response to an effective increase in [Ca2+]free, yet they possess either fewer Ca2+ sensors than native membranes or the existing sensors are significantly reduced in sensitivity with lower local cholesterol concentrations. This is consistent with previous studies that suggest a fundamental fusion machine of low calcium sensitivity, with associated factors that effectively bring triggering into the `physiological range' of Ca2+ sensitivities (Coorssen et al., 1998
; Coorssen et al., 2003
). Some sensors appear to be directly associated with the minimal fusion machinery and not lost during raft disruption, whereas other Ca2+ sensors are modulatory, acting to enhance the efficacy of the fusion reaction or post-fusion expansion of the pore (Scepek et al., 1998
). Thus, the concept of a single Ca2+ sensing protein regulating the triggering of membrane merger should perhaps be considered as a number of Ca2+ sensors or binding sites, either protein or lipid, which each contribute to the probability of triggering fusion at a given site.
The critical role of cholesterol in the process of Ca2+-triggered membrane merger neither unequivocally supports nor rules out a role for proteins in triggered fusion steps. It seems likely that the membrane components of all secretory vesicles have been highly `tuned' through evolution to allow variations in the extent, Ca2+ sensitivity and rate of fusion while preserving the same underlying molecular framework (Table 2). Evidence suggests that the energetic contributions of proteins alone may generally be insufficient to fully and effectively breach the hydration layer (Rand and Parsegian, 1989) or to effect complete bilayer merger (Coorssen et al., 2002
; Coorssen et al., 2003
; Szule et al., 2003
). The differential optimization of the vesicle lipidic matrix to facilitate the functions of the protein components of the fusion machine, might well explain differences in the rate and Ca2+ sensitivity of exocytotic release processes between different cell types and across species. Given the energetic complexity of the fusion process, necessitating inherent protein-lipid interactions in native membranes, we think it appropriate to consider cholesterol as a critical component of the minimal essential fusion machine. Cholesterol is responsible for the pre-fusion organization of components critical for Ca2+ sensing and contributing to the efficiency of fusion; a possible role for annular cholesterol in regulating the functions of specific proteins (such as the affinity of the Ca2+ sensors) must also be considered. Subsequently, cholesterol also contributes directly to the triggered fusion step, promoting fast fusion pore formation by virtue of its high focal native density and intrinsic negative curvature.
![]() |
Acknowledgments |
---|
![]() |
References |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Aachmann, F. L., Otzen, D. E., Larsen, K. L. and Wimmer, R. (2003). Structural background of cyclodextrin-protein interactions. Protein Eng. 16, 905-912.[CrossRef][Medline]
Alivisatos, S. G., Papastavrou, C., Drouka-Liapati, E., Molyvdas, A. P. and Nikitopoulou, G. (1977). Enzymatic and electrophysiological changes of the function of membrane proteins by cholesterol. Biochem. Biophys. Res. Commun. 79, 677-683.[CrossRef][Medline]
Awasthi-Kalia, M., Schnetkamp, P. P. and Deans, J. P. (2001). Differential effects of filipin and methyl-beta-cyclodextrin on B cell receptor signaling. Biochem. Biophys. Res. Commun. 287, 77-82.[CrossRef][Medline]
Bacia, K., Scherfeld, D., Kahya, N. and Schwille, P. (2004). Fluorescence correlation spectroscopy relates rafts in model and native membranes. Biophys. J. 87, 1034-1043.
Baker, P. F. and Whitaker, M. J. (1978). Influence of ATP and calcium on the cortical reaction in sea urchin eggs. Nature 276, 513-515.[CrossRef][Medline]
Baker, R. R., Dowdall, M. J. and Whittaker, V. P. (1975). The involvement of lysophosphoglycerides in neurotransmitter release; the composition and turnover of phospholipids of synaptic vesicles of guinea-pig cerebral cortex and Torpedo electric organ and the effect of stimulation. Brain Res. 100, 629-644.[CrossRef][Medline]
Bayer, M. J., Reese, C., Buhler, S., Peters, C. and Mayer, A. (2003). Vacuole membrane fusion: V0 functions after trans-SNARE pairing and is coupled to the Ca2+-releasing channel. J. Cell Biol. 162, 211-222.
Blank, P. S., Cho, M. S., Vogel, S. S., Kaplan, D., Kang, A., Malley, J. and Zimmerberg, J. (1998). Submaximal responses in calcium-triggered exocytosis are explained by differences in the calcium sensitivity of individual secretory vesicles. J. Gen. Physiol. 112, 559-567.
Blank, P. S., Vogel, S. S., Malley, J. D. and Zimmerberg, J. (2001). A kinetic analysis of calcium-triggered exocytosis. J. Gen. Physiol. 118, 145-156.
Blaschko, H., Firemark, H., Smith, A. D. and Winkler, H. (1967). Lipids of the adrenal medulla. Lysolecithin, a characteristic constituent of chromaffin granules. Biochem. J. 104, 545-549.[Medline]
Bligh, E. and Dyer, W. (1959). A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911-917.[Medline]
Bradford, A., Atkinson, J., Fuller, N. and Rand, R. P. (2003). The effect of vitamin E on the structure of membrane lipid assemblies. J. Lipid Res. 44, 1940-1945.
Breckenridge, W. C., Morgan, I. G., Zanetta, J. P. and Vincendon, G. (1973). Adult rat brain synaptic vesicles. II. Lipid composition. Biochim. Biophys. Acta 320, 681-686.[Medline]
Chamberlain, L. H., Burgoyne, R. D. and Gould, G. W. (2001). SNARE proteins are highly enriched in lipid rafts in PC12 cells: implications for the spatial control of exocytosis. Proc. Natl. Acad. Sci. USA 98, 5619-5624.
Chandler, D. E. (1984). Exocytosis in vitro: ultrastructure of the isolated sea urchin egg cortex as seen in platinum replicas. J. Ultrastruct. Res. 89, 198-211.[CrossRef][Medline]
Chanturiya, A., Chernomordik, L. V. and Zimmerberg, J. (1997). Flickering fusion pores comparable with initial exocytotic pores occur in protein-free phospholipid bilayers. Proc. Natl. Acad. Sci. USA 94, 14423-14428.
Chen, Z. and Rand, R. P. (1997). The influence of cholesterol on phospholipid membrane curvature and bending elasticity. Biophys. J. 73, 267-276.[Abstract]
Chernomordik, L. V. and Zimmerberg, J. (1995). Bending membranes to the task: structural intermediates in bilayer fusion. Curr. Opin. Struct. Biol. 5, 541-547.[CrossRef][Medline]
Chernomordik, L. V., Vogel, S. S., Sokoloff, A., Onaran, H. O., Leikina, E. A. and Zimmerberg, J. (1993). Lysolipids reversibly inhibit Ca(2+)-, GTP- and pH-dependent fusion of biological membranes. FEBS Lett. 318, 71-76.[CrossRef][Medline]
Chernomordik, L., Chanturiya, A., Green, J. and Zimmerberg, J. (1995a). The hemifusion intermediate and its conversion to complete fusion: regulation by membrane composition. Biophys. J. 69, 922-929.[Abstract]
Chernomordik, L., Kozlov, M. M. and Zimmerberg, J. (1995b). Lipids in biological membrane fusion. J. Membr. Biol. 146, 1-14.[Medline]
Christian, A. E., Haynes, M. P., Phillips, M. C. and Rothblat, G. H. (1997). Use of cyclodextrins for manipulating cellular cholesterol content. J. Lipid Res. 38, 2264-2272.[Abstract]
Coorssen, J. R. and Rand, R. P. (1990). Effects of cholesterol on the structural transitions induced by diacylglycerol in phosphatidylcholine and phosphatidylethanolamine bilayer systems. Biochem. Cell Biol. 68, 65-69.[Medline]
Coorssen, J. R. and Rand, R. P. (1995). Structural effects of neutral lipids on divalent cation-induced interactions of phosphatidylserine-containing bilayers. Biophys. J. 68, 1009-1018.[Abstract]
Coorssen, J. R., Blank, P. S., Tahara, M. and Zimmerberg, J. (1998). Biochemical and functional studies of cortical vesicle fusion: the SNARE complex and Ca2+ sensitivity. J. Cell Biol. 143, 1845-1857.
Coorssen, J. R., Blank, P. S., Albertorio, F., Bezrukov, L., Kolosova, I., Backlund, P. S., Jr and Zimmerberg, J. (2002). Quantitative femto- to attomole immunodetection of regulated secretory vesicle proteins critical to exocytosis. Anal. Biochem. 307, 54-62.[CrossRef][Medline]
Coorssen, J. R., Blank, P. S., Albertorio, F., Bezrukov, L., Kolosova, I., Chen, X., Backlund, P. S., Jr and Zimmerberg, J. (2003). Regulated secretion: SNARE density, vesicle fusion and calcium dependence. J. Cell Sci. 116, 2087-2097.
DaPrada, M., Pletscher, A. and Tranzer, J. P. (1972). Lipid composition of membranes of amine-storage organelles. Biochem. J. 127, 681-683.[Medline]
Decker, S. J. and Kinsey, W. H. (1983). Characterization of cortical secretory vesicles from the sea urchin egg. Dev. Biol. 96, 37-45.[CrossRef][Medline]
Deutsch, J. W. and Kelly, R. B. (1981). Lipids of synaptic vesicles: relevance to the mechanism of membrane fusion. Biochemistry 20, 378-385.[CrossRef][Medline]
Dreyfus, H., Aunis, D., Harth, S. and Mandel, P. (1977). Gangliosides and phospholipids of the membranes from bovine adrenal medullary chromaffin granules. Biochim. Biophys. Acta 489, 89-97.[Medline]
Elliott, M. H., Fliesler, S. J. and Ghalayini, A. J. (2003). Cholesterol-dependent association of caveolin-1 with the transducin alpha subunit in bovine photoreceptor rod outer segments: disruption by cyclodextrin and guanosine 5'-O-(3-thiotriphosphate). Biochemistry 42, 7892-7903.[CrossRef][Medline]
Epand, R. M., Fuller, N. and Rand, R. P. (1996). Role of the position of unsaturation on the phase behavior and intrinsic curvature of phosphatidylethanolamines. Biophys. J. 71, 1806-1810.[Abstract]
Feigenson, G. W. (1989). Calcium ion binding between lipid bilayers: the four-component system of phosphatidylserine, phosphatidylcholine, calcium chloride, and water. Biochemistry 28, 1270-1278.[CrossRef][Medline]
Filippov, A., Oradd, G. and Lindblom, G. (2003). The effect of cholesterol on the lateral diffusion of phospholipids in oriented bilayers. Biophys. J. 84, 3079-3086.
Fowler, S. D., Brown, W. J., Warfel, J. and Greenspan, P. (1987). Use of nile red for the rapid in situ quantitation of lipids on thin-layer chromatograms. J. Lipid Res. 28, 1225-1232.[Abstract]
Fratti, R. A., Jun, Y., Merz, A. J., Margolis, N. and Wickner, W. (2004). Interdependent assembly of specific regulatory lipids and membrane fusion proteins into the vertex ring domain of docked vacuoles. J. Cell Biol. 167, 1087-1098.
Gagescu, R., Demaurex, N., Parton, R. G., Hunziker, W., Huber, L. A. and Gruenberg, J. (2000). The recycling endosome of Madin-Darby canine kidney cells is a mildly acidic compartment rich in raft components. Mol. Biol. Cell 11, 2775-2791.
Grebe, M., Xu, J., Mobius, W., Ueda, T., Nakano, A., Geuze, H. J., Rook, M. B. and Scheres, B. (2003). Arabidopsis sterol endocytosis involves actin-mediated trafficking via ARA6-positive early endosomes. Curr. Biol. 13, 1378-1387.[CrossRef][Medline]
Gruner, S. M. (1985). Intrinsic curvature hypothesis for biomembrane lipid composition: a role for nonbilayer lipids. Proc. Natl. Acad. Sci. USA 82, 3665-3669.
Gunther-Ausborn, S., Praetor, A. and Stegmann, T. (1995). Inhibition of influenza-induced membrane fusion by lysophosphatidylcholine. J. Biol. Chem. 270, 29279-29285.
Han, X., Wang, C. T., Bai, J., Chapman, E. R. and Jackson, M. B. (2004). Transmembrane segments of syntaxin line the fusion pore of Ca2+-triggered exocytosis. Science 304, 289-292.
Hao, M., Lin, S. X., Karylowski, O. J., Wustner, D., McGraw, T. E. and Maxfield, F. R. (2002). Vesicular and non-vesicular sterol transport in living cells. The endocytic recycling compartment is a major sterol storage organelle. J. Biol. Chem. 277, 609-617.
Jin, A. J., Edidin, M., Nossal, R. and Gershfeld, N. L. (1999). A singular state of membrane lipids at cell growth temperatures. Biochemistry 38, 13275-13278.[CrossRef][Medline]
Kato, M. and Wickner, W. (2001). Ergosterol is required for the Sec18/ATP-dependent priming step of homotypic vacuole fusion. EMBO J. 20, 4035-4040.
Keenan, T. W., Sasaki, M., Eigel, W. N., Moore, D. J., Franke, W. W., Zulak, I. M. and Bushway, A. A. (1979). Characterization of a secretory vesicle-rich fraction from lactating bovine mammary gland. Exp. Cell Res. 124, 47-61.[CrossRef][Medline]
Keller, P. and Simons, K. (1998). Cholesterol is required for surface transport of influenza virus hemagglutinin. J. Cell Biol. 140, 1357-1367.
Kiely, J. M., Hu, Y., Garcia-Cardena, G. and Gimbrone, M. A., Jr (2003). Lipid raft localization of cell surface E-selectin is required for ligation-induced activation of phospholipase C gamma. J. Immunol. 171, 3216-3224.
Kilsdonk, E. P., Yancey, P. G., Stoudt, G. W., Bangerter, F. W., Johnson, W. J., Phillips, M. C. and Rothblat, G. H. (1995). Cellular cholesterol efflux mediated by cyclodextrins. J. Biol. Chem. 270, 17250-17256.
Kozlov, M. M. and Markin, V. S. (1983). [Possible mechanism of membrane fusion]. Biofizika 28, 242-247.[Medline]
Kozlovsky, Y., Chernomordik, L. V. and Kozlov, M. M. (2002). Lipid intermediates in membrane fusion: formation, structure, and decay of hemifusion diaphragm. Biophys. J. 83, 2634-2651.
Kuzmin, P. I., Zimmerberg, J., Chizmadzhev, Y. A. and Cohen, F. S. (2001). A quantitative model for membrane fusion based on low-energy intermediates. Proc. Natl. Acad. Sci.USA 98, 7235-7240.
Lagercrantz, H. (1971). Lipids of the sympathetic nerve trunk vesicles. Comparison with adrenomedullary vesicles. Acta Physiol. Scand. 82, 567-570.[Medline]
Lang, T., Bruns, D., Wenzel, D., Riedel, D., Holroyd, P., Thiele, C. and Jahn, R. (2001). SNAREs are concentrated in cholesterol-dependent clusters that define docking and fusion sites for exocytosis. EMBO J. 20, 2202-2213.
Leikin, S., Kozlov, M. M., Fuller, N. L. and Rand, R. P. (1996). Measured effects of diacylglycerol on structural and elastic properties of phospholipid membranes. Biophys. J. 71, 2623-2632.[Abstract]
Leventis, R. and Silvius, J. R. (2001). Use of cyclodextrins to monitor transbilayer movement and differential lipid affinities of cholesterol. Biophys. J. 81, 2257-2267.
Lindau, M. and Almers, W. (1995). Structure and function of fusion pores in exocytosis and ectoplasmic membrane fusion. Curr. Opin. Cell Biol. 7, 509-517.[CrossRef][Medline]
Lopes, S. C., Goormaghtigh, E., Cabral, B. J. and Castanho, M. A. (2004). Filipin orientation revealed by linear dichroism. Implication for a model of action. J. Am. Chem. Soc. 126, 5396-5402.[CrossRef][Medline]
Lucero, H. A. and Robbins, P. W. (2004). Lipid rafts-protein association and the regulation of protein activity. Arch. Biochem. Biophys. 426, 208-224.[CrossRef][Medline]
Luzzati, V. and Husson, F. (1962). The structure of the liquid-crystalline phasis of lipid-water systems. J. Cell Biol. 12, 207-219.
Meldolesi, J., Jamieson, J. D. and Palade, G. E. (1971). Composition of cellular membranes in the pancreas of the guinea pig. II. Lipids. J. Cell Biol. 49, 130-149.
Michaelson, D. M., Barkai, G. and Barenholz, Y. (1983). Asymmetry of lipid organization in cholinergic synaptic vesicle membranes. Biochem. J. 211, 155-162.[Medline]
Nagy, A., Baker, R. R., Morris, S. J. and Whittaker, V. P. (1976). The preparation and characterization of synaptic vesicles of high purity. Brain Res. 109, 285-309.[CrossRef][Medline]
Norman, A. W., Demel, R. A., de Kruyff, B., Geurts van Kessel, W. S. and van Deenen, L. L. (1972a). Studies on the biological properties of polyene antibiotics: comparison of other polyenes with filipin in their ability to interact specifically with sterol. Biochim. Biophys. Acta 290, 1-14.[Medline]
Norman, A. W., Demel, R. A., de Kruyff, B. and van Deenen, L. L. (1972b). Studies on the biological properties of polyene antibiotics. Evidence for the direct interaction of filipin with cholesterol. J. Biol. Chem. 247, 1918-1929.
Ohara-Imaizumi, M., Nishiwaki, C., Kikuta, T., Kumakura, K., Nakamichi, Y. and Nagamatsu, S. (2004). Site of docking and fusion of insulin secretory granules in live MIN6 beta cells analyzed by TAT-conjugated anti-syntaxin 1 antibody and total internal reflection fluorescence microscopy. J. Biol. Chem. 279, 8403-8408.
Orci, L., Montesano, R., Meda, P., Malaisse-Lagae, F., Brown, D., Perrelet, A. and Vassalli, P. (1981). Heterogeneous distribution of filipincholesterol complexes across the cisternae of the Golgi apparatus. Proc. Natl. Acad. Sci. USA 78, 293-297.
Parasassi, T., Giusti, A. M., Raimondi, M. and Gratton, E. (1995). Abrupt modifications of phospholipid bilayer properties at critical cholesterol concentrations. Biophys. J. 68, 1895-1902.[Abstract]
Patterson, J., Holland, J. and Bieber, L. L. (1979). Studies on the competition of polyene antibiotics for sterols. J. Antibiot. (Tokyo). 32, 646-653.[Medline]
Peters, C. and Mayer, A. (1998). Ca2+/calmodulin signals the completion of docking and triggers a late step of vacuole fusion. Nature 396, 575-580.[CrossRef][Medline]
Peters, C., Andrews, P. D., Stark, M. J., Cesaro-Tadic, S., Glatz, A., Podtelejnikov, A., Mann, M. and Mayer, A. (1999). Control of the terminal step of intracellular membrane fusion by protein phosphatase 1. Science 285, 1084-1087.
Peters, C., Bayer, M. J., Buhler, S., Andersen, J. S., Mann, M. and Mayer, A. (2001). Trans-complex formation by proteolipid channels in the terminal phase of membrane fusion. Nature 409, 581-588.[CrossRef][Medline]
Racchi, M., Baetta, R., Salvietti, N., Ianna, P., Franceschini, G., Paoletti, R., Fumagalli, R., Govoni, S., Trabucchi, M. and Soma, M. (1997). Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content. Biochem. J. 322, 893-898.[Medline]
Rand, R. P. and Parsegian, V. A. (1989). Hydration forces between phospholipid bilayers. Biochim. Biophys. Acta 988, 351-376.
Rand, R. P., Fuller, N. L., Gruner, S. M. and Parsegian, V. A. (1990). Membrane curvature, lipid segregation, and structural transitions for phospholipids under dual-solvent stress. Biochemistry 29, 76-87.[CrossRef][Medline]
Rilfors, L. and Lindblom, G. (2002). Regulation of lipid composition in biological membranesbiophysical studies of lipids and lipid synthesizing enzymes. Colloid. Surface. B 26, 112-124.[CrossRef]
Salaun, C., Gould, G. W. and Chamberlain, L. H. (2005). Lipid raft association of SNARE proteins regulates exocytosis in PC12 cells. J. Biol. Chem. 280, 19449-19453.
Samsonov, A. V., Mihalyov, I. and Cohen, F. S. (2001). Characterization of cholesterol-sphingomyelin domains and their dynamics in bilayer membranes. Biophys. J. 81, 1486-1500.
Sanina, N. M. and Kostetsky, E. Y. (2002). Thermotropic behavior of major phospholipids from marine invertebrates: changes with warm-acclimation and seasonal acclimatization. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 133, 143-153.[Medline]
Scepek, S., Coorssen, J. R. and Lindau, M. (1998). Fusion pore expansion in horse eosinophils is modulated by Ca2+ and protein kinase C via distinct mechanisms. EMBO J. 17, 4340-4345.
Shafi, N. I., Vogel, S. S. and Zimmerberg, J. (1994). Using caged calcium to study sea urchin egg cortical granule exocytosis in vitro. Methods. 6, 82-92.[CrossRef]
Sheets, E. D., Holowka, D. and Baird, B. (1999). Critical role for cholesterol in Lyn-mediated tyrosine phosphorylation of FcepsilonRI and their association with detergent-resistant membranes. J. Cell Biol. 145, 877-887.
Siegel, D. P. (1993). Energetics of intermediates in membrane fusion: comparison of stalk and inverted micellar intermediate mechanisms. Biophys. J. 65, 2124-2140.[Abstract]
Steck, T. L., Ye, J. and Lange, Y. (2002). Probing red cell membrane cholesterol movement with cyclodextrin. Biophys. J. 83, 2118-2125.
Szule, J. A., Jarvis, S. E., Hibbert, J. E., Spafford, J. D., Braun, J. E., Zamponi, G. W., Wessel, G. M. and Coorssen, J. R. (2003). Calcium-triggered membrane fusion proceeds independently of specific presynaptic proteins. J. Biol. Chem. 278, 24251-24254.
Tahara, M., Coorssen, J. R., Timmers, K., Blank, P. S., Whalley, T., Scheller, R. and Zimmerberg, J. (1998). Calcium can disrupt the SNARE protein complex on sea urchin egg secretory vesicles without irreversibly blocking fusion. J. Biol. Chem. 273, 33667-33673.
Vacquier, V. D. (1975). The isolation of intact cortical granules from sea urchin eggs: calcium lons trigger granule discharge. Dev. Biol. 43, 62-74.[CrossRef][Medline]
Vogel, S. S., Delaney, K. and Zimmerberg, J. (1991). The sea urchin cortical reaction. A model system for studying the final steps of calcium-triggered vesicle fusion. Ann. New York Acad. Sci. 635, 35-44.[Medline]
Vogel, S. S., Leikina, E. A. and Chernomordik, L. V. (1993). Lysophosphatidylcholine reversibly arrests exocytosis and viral fusion at a stage between triggering and membrane merger. J. Biol. Chem. 268, 25764-25768.
Vogel, S. S., Blank, P. S. and Zimmerberg, J. (1996). Poisson-distributed active fusion complexes underlie the control of the rate and extent of exocytosis by calcium. J. Cell Biol. 134, 329-338.[Abstract]
Weerheim, A. M., Kolb, A. M., Sturk, A. and Nieuwland, R. (2002). Phospholipid composition of cell-derived microparticles determined by one-dimensional high-performance thin-layer chromatography. Anal. Biochem. 302, 191-198.[CrossRef][Medline]
Weissmann, G. and Sessa, G. (1967). The action of polyene antibiotics on phospholipid-cholesterol structures. J. Biol. Chem. 242, 616-625.
Whalley, T., Timmers, K., Coorssen, J., Bezrukov, L., Kingsley, D. H. and Zimmerberg, J. (2004). Membrane fusion of secretory vesicles of the sea urchin egg in the absence of NSF. J. Cell Sci. 117, 2345-2356.
White, D. A. and Hawthorne, J. N. (1970). Zymogen secretion and phospholipid metabolism in the pancreas. Phospholipids of the zymogen granule. Biochem. J. 120, 533-538.[Medline]
Xu, X. and London, E. (2000). The effect of sterol structure on membrane lipid domains reveals how cholesterol can induce lipid domain formation. Biochemistry 39, 843-849.[CrossRef][Medline]
Zimmerberg, J., Blank, P. S., Kolosova, I., Cho, M. S., Tahara, M. and Coorssen, J. R. (2000). A stage-specific preparation to study the Ca(2+)-triggered fusion steps of exocytosis: rationale and perspectives. Biochimie 82, 303-314.[CrossRef][Medline]
Zinder, O., Hoffman, P. G., Bonner, W. M. and Pollard, H. B. (1978). Comparison of chemical properties of purified plasma membranes and secretory vesicle membranes from bovine adrenal medulla. Cell Tissue Res. 188, 153-170.[Medline]
Related articles in JCS: